TACCONELLI, Evelina
 Distribuzione geografica
Continente #
EU - Europa 4.167
NA - Nord America 3.524
AS - Asia 1.260
SA - Sud America 28
AF - Africa 20
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 10
Totale 9.024
Nazione #
US - Stati Uniti d'America 3.510
GB - Regno Unito 1.216
CN - Cina 1.054
IT - Italia 1.019
FR - Francia 501
IE - Irlanda 489
SE - Svezia 396
DE - Germania 281
FI - Finlandia 125
HK - Hong Kong 52
VN - Vietnam 43
UA - Ucraina 39
RU - Federazione Russa 28
TR - Turchia 21
KR - Corea 20
BE - Belgio 17
IN - India 16
AU - Australia 14
NL - Olanda 14
BR - Brasile 12
CA - Canada 10
EU - Europa 10
PK - Pakistan 10
TW - Taiwan 10
GR - Grecia 9
JP - Giappone 8
AT - Austria 7
RO - Romania 7
CL - Cile 6
EG - Egitto 5
PH - Filippine 5
SA - Arabia Saudita 5
GH - Ghana 4
MY - Malesia 4
ZA - Sudafrica 4
AR - Argentina 3
CH - Svizzera 3
ES - Italia 3
PE - Perù 3
PL - Polonia 3
BG - Bulgaria 2
CO - Colombia 2
EC - Ecuador 2
HU - Ungheria 2
ID - Indonesia 2
IL - Israele 2
KE - Kenya 2
TZ - Tanzania 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BZ - Belize 1
DK - Danimarca 1
GL - Groenlandia 1
IQ - Iraq 1
IR - Iran 1
JO - Giordania 1
LK - Sri Lanka 1
LV - Lettonia 1
MA - Marocco 1
MS - Montserrat 1
MW - Malawi 1
MX - Messico 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
SG - Singapore 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 9.024
Città #
Southend 1.176
Chandler 959
Verona 482
Dublin 471
Ashburn 283
Beijing 229
Redmond 224
Lawrence 175
Princeton 175
New York 156
Jacksonville 150
Wilmington 125
Jinan 98
Nanjing 81
Sindelfingen 81
Helsinki 76
Shenyang 73
Seattle 53
Ann Arbor 50
Haikou 44
Hong Kong 44
Tianjin 41
Lappeenranta 40
Hebei 39
Boydton 38
Bologna 37
Nanchang 36
Ningbo 36
Zhengzhou 35
Changsha 34
Houston 30
Dong Ket 29
Jiaxing 27
Washington 25
Hangzhou 22
Taizhou 22
Woodbridge 22
Taiyuan 21
Seoul 20
Norwalk 19
San Francisco 19
Milan 18
Redwood City 18
Sant'Ambrogio di Valpolicella 18
Brussels 17
Bussolengo 17
Guangzhou 17
Dongguan 16
Fairfield 16
Chicago 15
Chions 15
Los Angeles 14
London 12
Berlin 11
Rovereto 11
Tappahannock 11
Lahore 10
Lanzhou 9
Roverbella 8
Brescia 7
Clearwater 7
Coventry 7
Dossobuono 7
Fuzhou 7
Saint Petersburg 7
Tombolo 7
Toronto 7
Frankfurt am Main 6
Leawood 6
Nuremberg 6
Trento 6
Vienna 6
Cairo 5
Canberra 5
Isola della Scala 5
Kocaeli 5
Kochi 5
Misterbianco 5
Naples 5
San Giovanni Lupatoto 5
Taipei 5
Accra 4
Bolzano 4
Cambridge 4
Cerea 4
Grezzana 4
Kuala Lumpur 4
Monza 4
Moscow 4
Paris 4
San Diego 4
Sydney 4
Amsterdam 3
Arzignano 3
Boardman 3
Borgo Valsugana 3
Bowling Green 3
Buenos Aires 3
Central 3
Columbus 3
Totale 6.249
Nome #
Management of obstetrics and gynaecological patients with COVID-19 102
Active surveillance for early detection of SARS-CoV-2 infections across high-risk community key populations. 91
Metallo-b-lactamases as emerging resistance determinants in gram-negative pathogens: open issues 90
BaiCD gene cluster abundance is negatively correlated with Clostridium difficile infection 83
Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic 81
Deep vein thrombosis in SARS-CoV-2 pneumonia-affected patients within standard care units: exploring a submerged portion of the iceberg. 79
Agreement among healthcare professionals in ten European countries in diagnosing case-vignettes of surgical-site infections 79
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis 78
Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli 76
Deciphering the state of immune silence in fatal COVID-19 patients 75
Nucleic-acid-amplification tests from respiratory samples for the diagnosis of coronavirus infections: systematic review and meta-analysis 74
Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group 74
Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis 73
Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients 73
Clinical management of severe infections caused by carbapenem-resistant Gram-negative bacteria: a worldwide cross-sectional survey addressing the use of antibiotic combinations 73
Long-Term Patient-Centred Follow-up in a Prospective Cohort of Patients with COVID-19 70
A survey of methicillin-resistant Staphylococcus aureus control strategies in Italy 69
European Society of clinical microbiology and infectious diseases (ESCMID) guidelines for the treatment of infections caused by Multidrug-resistant Gram-negative bacilli (endorsed by ESICM -European Society of intensive care Medicine) 69
[Antibiotic Stewardship 2.0. Individualization of therapy] 68
Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study 68
Fatal cytokine release syndrome by an aberrant FLIP/STAT3 axis 68
Prevalence of antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis in World Health Organization regions 67
Metallo-beta-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues 66
Acute kidney injury and tools for risk-stratification in 456 patients with hantavirus-induced nephropathia epidemica 66
Gross national income and antibiotic resistance in invasive isolates: analysis of the top-ranked antibiotic-resistant bacteria on the 2017 WHO priority list 66
Development and validation of a multiplex PCR assay for identification of the epidemic ST-258/512 KPC-producing Klebsiella pneumoniae clone 66
Is there still a role for vancomycin in skin and soft-tissue infections? 65
Actinomyces osteomyelitis in bisphosphonate-related osteonecrosis of the jaw (BRONJ): the missing link? 65
Emotional, cognitive and social factors of antimicrobial prescribing: can antimicrobial stewardship intervention be effective without addressing psycho-social factors? 65
Assessment of COVID-19 progression on day 5 from symptoms onset 65
Antimicrobial resistance rates in gram-positive bacteria do not drive glycopeptides use 64
Combination versus monotherapy for the treatment of infections due to carbapenem-resistant Enterobacteriaceae 64
Antibiotic research and development: business as usual? 61
A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae 61
The serological prevalence of SARS-CoV-2 infection in patients with chronic myeloid leukemia is similar to that in the general population 61
COVID-19 seroprevalence amongst healthcare workers: potential biases in estimating infection prevalence 61
Susceptibility to cephalosporin combinations and aztreonam/avibactam among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission 60
Low plasmatic concentration of intensified antiretroviral therapy in a pregnant woman: a case report 60
Outbreak of Saprochaete clavata Sepsis in Hematology Patients: Combined Use of MALDI-TOF and Sequencing Strategy to Identify and Correlate the Episodes 59
Role of new antibiotics for KPC-producing Klebsiella pneumoniae 59
How to ‘SAVE’ antibiotics: effectiveness and sustainability of a new model of antibiotic stewardship intervention in the internal medicine area 58
Aggressive versus conservative initiation of antibiotics 58
Efficacy and safety of abacavir/lamivudine with raltegravir in treatment-experienced and treatment-naïve patients with HIV-1 infection: an observational, retrospective, multi-centre study 58
A 2020 review on the role of procalcitonin in different clinical settings: an update conducted with the tools of the Evidence Based Laboratory Medicine 58
White Paper: Bridging the gap between surveillance data and antimicrobial stewardship in the animal sector-practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks 58
The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals, 2010 and 2011: a multicentre retrospective cohort study 57
Analysis of the challenges in implementing guidelines to prevent the spread of multidrug-resistant gram-negatives in Europe 57
Translational research strategy: an essential approach to fight the spread of antimicrobial resistance 57
Development and validation of BLOOMY prediction scores for 14-day and 6-month mortality in hospitalised adults with bloodstream infections: a multicentre, prospective, cohort study 57
A large survey among European trainees in clinical microbiology and infectious disease on training systems and training adequacy: identifying the gaps and suggesting improvements 56
Increase in visceral adipose tissue in a woman living with HIV after introduction of integrase strand transfer inhibitor 56
White Paper: Bridging the gap between surveillance data and antimicrobial stewardship in long-term care facilities-practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks 56
Methodological quality of studies evaluating the burden of drug-resistant infections in humans due to the WHO Global Antimicrobial Resistance Surveillance system target bacteria 56
Clinical outcome in solid organ transplant recipients affected by COVID-19 compared to general population: a systematic review and meta-analysis 56
Broadening the infection prevention and control network globally; 2017 Geneva IPC-think tank (part 3) 55
Mandatory surveillance and outbreaks reporting of the WHO priority pathogens for research & Discovery of new antibiotics in European countries 55
White Paper: Bridging the gap between surveillance data and antimicrobial stewardship in the outpatient sector-practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks 55
Public health burden of antimicrobial resistance in Europe 54
Determinants of Persistence of Symptoms and Impact on Physical and Mental Wellbeing in Long COVID: A Prospective Cohort Study 54
ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients 53
Geographical variability in the likelihood of bloodstream infections due to gram-negative bacteria: correlation with proximity to the equator and health care expenditure 53
Systematic literature review of the burden and outcomes of infections due to multidrug-resistant organisms in Europe: the ABOUT-MDRO project protocol 53
Linking antimicrobial resistance surveillance to antibiotic policy in healthcare settings: the COMBACTE-Magnet EPI-Net COACH project 53
EpideMiology and control measures of outBreaks due to Antibiotic-Resistant orGanisms in EurOpe (EMBARGO): a systematic review protocol 53
The association between antimicrobial resistance and HIV infection: a systematic review and meta-analysis 53
A case study on Staphylococcus aureus bacteraemia: available treatment options, antibiotic R&D and responsible antibiotic-use strategies 53
MRSA infections among patients in the emergency department: a European multicentre study 52
[Infectious diseases as a clinical specialty in Germany and Europe] 52
Gender differences in antibiotic prescribing in the community: a systematic review and meta-analysis 52
The pharmacokinetics and pharmacodynamics of vancomycin in clinical practice: evidence and uncertainties 52
High rate of pulmonary thromboembolism in patients with SARS-CoV-2 pneumonia 52
A Review of Vaccinations in Adult Patients with Secondary Immunodeficiency 52
VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment 52
ESCMID-EUCIC clinical guidelines on decolonisation of multidrug-resistant Gram-negative bacteria carriers 51
Pitfalls of Computed Tomography in the Coronavirus 2019 (COVID-19) Era: A New Perspective on Ground-Glass Opacities 51
Nervous system: subclinical target of SARS-CoV-2 infection 51
Infection Risk in Sterile Operative Procedures 50
Science without meritocracy. Discrimination among European specialists in infectious diseases and clinical microbiology: a questionnaire survey 50
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study 50
Social media posts and online search behaviour as early-warning system for MRSA outbreaks 50
The antimicrobial resistance travel tool, an interactive evidence-based educational tool to limit antimicrobial resistance spread 50
Multi-Criteria Decision Analysis to prioritize hospital admission of patients affected by COVID-19 in low-resource settings with hospital-bed shortage 49
The Innovative Medicines Initiative's New Drugs for Bad Bugs programme: European public-private partnerships for the development of new strategies to tackle antibiotic resistance 49
Systematic literature analysis and review of targeted preventive measures to limit healthcare-associated infections by meticillin-resistant Staphylococcus aureus 49
Dolutegravir monotherapy and body weight gain in antiretroviral naïve patients 49
Beyond COVID-19-a paradigm shift in infection management? 49
Estimating the association between antibiotic exposure and colonisation with ESBL-producing Gram negative bacteria: a multicentre, prospective cohort study 49
Diagnostic accuracy of point-of-care tests in acute community acquired-lower respiratory tract infections. A systematic review and meta-analysis 49
Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extended-spectrum-β-lactamase-producing Enterobacteriaceae 48
[Erratum to: Antibiotic Stewardship 2.0 : Individualization of therapy] 48
Comparison of Predictors and Mortality Between Bloodstream Infections Caused by ESBL-Producing Escherichia coli and ESBL-Producing Klebsiella pneumoniae. 48
Combination therapy for carbapenem-resistant Gram-negative bacteria 47
Impact of availability of guidelines and active surveillance in reducing the incidence of ventilator-associated pneumonia in Europe and worldwide 47
Impact of implementing a non-restrictive antibiotic stewardship program in an emergency department: a four-year quasi-experimental prospective study 47
The role of combination therapy in the treatment of severe infections caused by carbapenem resistant gram-negatives: a systematic review of clinical studies 47
Controversies in guidelines for the control of multidrug-resistant Gram-negative bacteria in EU countries 46
Colonization with third-generation cephalosporin-resistant Enterobacteriaceae on hospital admission: prevalence and risk factors 46
Evaluation of the scientific impact of the Ebola epidemic: a systematic review 46
New antibiotics for skin and skin-structure infections 45
Variation of effect estimates in the analysis of mortality and length of hospital stay in patients with infections caused by bacteria-producing extended-spectrum beta-lactamases: a systematic review and meta-analysis 45
Totale 5.926
Categoria #
all - tutte 39.956
article - articoli 39.673
book - libri 0
conference - conferenze 283
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.912


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201948 0 0 0 0 0 0 0 0 0 0 12 36
2019/2020812 117 6 6 26 229 40 71 60 50 49 62 96
2020/20211.336 104 216 47 225 154 92 34 63 71 87 165 78
2021/20221.516 161 303 44 39 39 47 26 137 148 53 113 406
2022/20233.222 201 366 300 583 218 775 40 219 337 30 90 63
2023/20241.795 98 142 156 223 293 370 155 199 14 123 22 0
Totale 9.547